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 Fecal samples were collected from market hogs (n=82) and steers (n=84) at a 
statewide livestock show in Texas. Samples were analyzed to determine the prevalence and 
antimicrobial susceptibility of generic Escherichia coli and Salmonella spp. Escherichia coli 
populations were higher in hogs with an LSMean of 6.12 log10 CFU/g of feces compared to 
steer samples at 5.57 log10 CFU/g (P<0.05). Salmonella was more prevalent in hog fecal 
samples than steer samples (P<0.05) with 19.05% of hogs and 3.61% steers testing positive. 
Microbroth dilution plates were used to evaluate antimicrobial susceptibility. Market hog E. 
coli isolates (n=330) were resistant to Tetracycline and Sulfisoxazole with values of 96.67% 
and 69.70%; whereas steer isolates (n=332) were resistant to Tetracycline and Streptomycin 
with values of 55.12% and 32.53%, respectively. Market hog Salmonella isolates (n=18) 
were resistant to Tetracycline with a value of 77.78%; whereas steer isolates (n=5) were 
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 Livestock shows have played an important role for families in Texas since the 
establishment of the first statewide livestock show in 1886 (SFT, 2016). Livestock shows 
primarily consist of animal exhibits such as cattle, hogs, sheep, and goats. While these 
animals may be washed and cleaned on a daily basis (Texas Cooperative Extension, 2001), 
there are concerns with bacteria, such as Escherichia coli (E. coli) and Salmonella, that are 
often found in the feces of these animals (Keen et al., 2006; Croxen et al., 2013; Roug et al., 
2013; Sahl et al., 2013). Many studies have indicated that bacteria can be spread through 
human contact with contaminated animal feces or surfaces around livestock due to proper 
hygiene practices not being utilized (Keen et al., 2006; Pabilonia et al., 2014). Moreover, the 
show animals that are designated as “market livestock” will eventually be introduced to the 
human food supply. Along with concerns of bacterial presence in feces which could lead to 
traditional foodborne illnesses, antibiotic resistant infection is becoming even more of a 
public concern. Bacteria have the ability to naturally evolve and resistance genes may be 
transferred in mobile genetic elements through horizontal gene transfer (MacGowen and 
Macnaughton, 2013; Brown-Jaque et al., 2015). Antibiotic resistance is a dynamic issue for 
both humans and animals. However, little research focuses on where market show animals fit 
into that dynamic. The objectives of this study were to: 1) determine the prevalence of 
generic E. coli and Salmonella spp. in the feces of market show hogs and steers, 2) determine 
the antimicrobial susceptibility profiles of both pathogens, and 3) determine differences of 
antibiotic resistance levels in bacteria from market swine and cattle.  
__________ 





 Escherichia coli (E. coli) is a gram-negative, non-sporulating facultative anaerobe 
typically found in the gastrointestinal tract of humans and animals (Tenaillon et al., 2010; 
Sahl et al., 2013). E. coli is a member of the Enterobacteriaceae bacterial group. While many 
strains of E. coli are considered to be nonpathogenic, or commensal, E. coli has the ability to 
adapt and some strains may develop virulent genes (Wells et al., 2014). Bray (1945) is 
responsible for the first recognition of E. coli being pathogenic. Further research on E. coli 
has led to a greater understanding of the bacteria itself plus various strains. For instance, in 
humans there are several pathotypes of E. coli that are classified as enterovirulent. These 
strains are split into several categories such as enterotoxigenic (ETEC), enteropathogenic 
(EPEC), enteroaggregative (EAggEC), enteroinvasive (EIEC), enterohemorrhagic (EHEC), 
and diffusely adherent (DAEC) (CDC, 2015a; Wells et al., 2014). Enteroinvasive and 
enteroaggregative are both commonly associated with gastrointestinal (GI) disease in humans 
whereas enterotoxigenic, enteropathogenic, and enterohemorrhagic cause GI issues in not 
only humans but can also infect and colonize in other animals. In terms of food safety issues, 
EHEC is associated with producing shiga toxins (Kaper et al., 2004). Even though shiga-
toxin producing E. coli (STEC) are primarily found in the gastrointestinal tract of ruminant 
animals, humans are at risk of infection via foodborne illnesses often obtained through meat 
products contaminated with feces containing STEC (Croxen et al., 2013). Likewise, E. coli 
O157:H7 is classified as an EHEC and STEC strain (Wells et al., 2014). This particular strain 
of E. coli, may lead to Hemorrhagic Colitis and Hemolytic Uremic Syndrome in humans; 
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while the latter may result in kidney failure, thereby leading to the death of infected 
individuals (Corrigan et al., 2001). 
 Commensal Escherichia coli strains are the non-pathogenic form of E. coli. 
Commensal strains can be found in the large intestine and they primarily dwell in the mucus 
layer covering the epithelial tissue of the digestive tract. The commensal strains will often be 
shed with the mucus passing through the tract and exit the body with fecal material 
(Tenaillon et al., 2010). Strains that are not located in the large intestine will survive off of 
nutrients found in the mucus (Chang et al., 2004). Escherichia coli is one of the first bacteria 
that will inhabit the gastrointestinal tract of humans when they are just mere infants. As 
humans reach the elderly age, the population of E. coli will begin to decrease (Penders et al., 
2006). One of the benefits to having commensal E. coli in the large intestine is that they will 
often act to prevent other pathogenic bacteria from colonizing (Tenaillon, 2010).  
Salmonella spp. 
 Salmonella spp. are considered to be a gram-negative bacillus (rod shaped) bacteria 
that live in the gastrointestinal tracts of both humans and animals (USDA-FSIS, 2013). 
Salmonella spp. are known to cause the foodborne infection Salmonellosis (USDA-FSIS, 
2013; Callaway et al., 2008). Foodborne infections are a result of individuals eating foods 
that contain live pathogens which then grow in the intestines and cause illnesses. There are 
several types of food that, if contaminated, may aid in transferring Salmonella to humans. 
These foods include any meat product that is raw or undercooked, dairy products, vegetables, 
fruits, and even eggs (Maldonado et al., 2013; USDA-FSIS, 2013; Foley et al., 2008). Within 
the genus Salmonella, there are two species, S. enterica and S. bongori. Salmonella enterica 
is further divided into six subspecies that encompass over 2,500 unique serovars (Coburn et 
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al., 2007). Serovars within S. enterica are often associated with causing foodborne illness in 
both humans and animals. Salmonella Dublin, Salmonella Typhimurium, and Salmonella 
Choleraesuis are a few examples of serovars that occur in humans and animals, but each is 
host specific to a different animal. According to USDA-FSIS (2015), S. Enteritidis and S. 
Typhimurium are the two most commonly associated with human foodborne infections. 
Show Animals and Pathogens of Importance 
Cattle and hogs have served a dual purpose for many years. While some people might 
own them as commercial livestock, others may only use them for participating in livestock 
shows. Livestock shows have played an important role for families in Texas since the 
establishment of the first statewide livestock show in 1886 (SFT, 2016). Any livestock that 
are destined to be utilized as show animals are often maintained separately from the herd 
where they originally came from or in smaller group settings (Texas Cooperative Extension, 
2001). Youth across Texas are required to complete training and assessment on good 
management practices, keeping food quality and safety as top priority, before they can 
validate their animals for eligibility to compete in a statewide show (TAMAE, 2016). Daily 
hygienic routines for market show livestock consist of rinsing or washing and cleaning the 
animals starting several months prior to show and throughout show times. It is highly 
encouraged that exhibitors maintain cleanliness of their animals and individual stalls or 
designated spot on the rail; plus walkways, pathways, or aisles where people and other 
animals may travel through. 
Keen et al. (2006) performed a study that delved into the issue of the presence of 
Shiga-toxigenic E. coli O157:H7 at agricultural fairs in the United States. In 2002, 2,919 
fecal samples were collected in two states at 29 county fairs, as well as three state fairs. 
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Results confirmed that STEC O157:H7 was prevalent in livestock at 31 of 32 fairs. 
Furthermore, cattle were the primary carriers with 1,407 (11.4% of samples) positive results. 
Prevalence in other species such as swine and sheep and goats were 1.2% of 1,102 and 3.6% 
of 364, respectively. Given the brief explanation of livestock exhibit management, it is vital 
to note that Keen et al. (2006) hypothesized that there would be lower STEC O157 levels in 
show animals versus commercially raised livestock. However, upon completion of their 
study, data demonstrated that prevalence of STEC O157:H7 in livestock show animals at 
fairs is similar to animals that were raised in commercial settings (e.g. feedlots). However, 
with proper sanitation practices, such as washing hands after touching livestock exhibits, the 
risk of humans contracting STEC O157, and other bacterial risks, can be decreased. 
Salmonella was detected on various environmental surfaces (feed, cages, tables, and floors) 
at poultry exhibits within county fairs (Pabilonia et al., 2014). Of those samples collected, 
they found that at least one sample was positive from 10 out of 11 fairs; with eleven different 
serovars detected after isolation. It was concluded that possible Salmonella contamination 
could be spread from the environmental surfaces to exhibitors, thereby causing the 
contamination to spread to other surfaces or people (Pabilonia et al., 2014). This particular 
study was conducted seven years after the E. coli study by Keen et al. (2006) whose samples 
were collected in 2002. It is evident that the recurring theme of utilizing proper hygiene at 
fairs continues to remain imperative. 
Antibiotic Use 
 In humans, there are different antimicrobials that may be used to treat E. coli 
infections and Salmonellosis. According to Madappa and Hiong (2015), ampicillin and 
sulbactam (or cefoxitin) may be used to treat intra-abdominal abscesses from E. coli whereas 
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doxycycline, fluoroquinolonones, and rifaxmin can treat Traveler’s Diarrhea (an enteric 
infection). Salmonella infections leading to Salmonellosis can be treated with ciprofloxacin, 
azithromycin, ceftriaxone, trimethoprim and sulfamethoxazole, and chloramphenicol 
(Klochko and Wallace, 2015). 
For livestock, antimicrobials that are utilized in the form of injections have 
withdrawal periods. Withdrawal periods are defined as the number of days a producer must 
wait for the antibiotic residues to be out of the animal’s system prior to being sent to 
slaughter, where its meat products will eventually be consumed, and even residues that may 
be in milk and eggs (McEwen and Fedorka-Cray, 2002). Treatment of various infections in 
cattle can include antibiotics such as amoxicillin, erythromycin, fluoroquinolone, penicillin, 
sulfonamides, and tylosin. In swine, amoxicillin, ampicillin, chlortetracyline, sulfamethazine, 
and tylosin can be used to treat various infections (McEwen and Fedorka-Cray, 2002). The 
Food and Drug Administration deemed antibiotic use to prevent, control, or treat certain 
diseases as judicious uses for antibiotics (FDA, 2012). Off-label use, such as using an 
antimicrobial to increase rate of gain in food animals, of the aforementioned drugs is 
considered to be injudicious and is prohibited (FDA, 2012; FDA, 2013).  
Antimicrobial Resistance 
Antimicrobial resistance (AMR) occurs when a microbe, pathogenic or 
nonpathogenic, demonstrates partial or full resistance to antimicrobials; after this occurs it is 
susceptible to absorbing genes that encode for AMR (Brown-Jaque et al., 2015; MacGowen 
and Macnaughton, 2013). Antimicrobial resistance genes can be carried on Mobile Genetic 
Elements (MGE) and can be transferred by Horizontal Gene Transfer (HGT) (Brown-Jaque 
et al., 2015; MacGowen and Macnaughton, 2013). The MGEs consist of plasmids and 
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transposons. Both MGE and HGT utilize conjugation, transduction, and transformation to 
transfer genes from host to host (Brown-Jaque et al., 2015; MacGowen and Macnaughton, 
2013; Gogarten and Townsend, 2005). Conjugation occurs when there is direct cell to cell 
contact with plasmid transfer. Transduction is responsible for transferring bacterial DNA via 
bacteriophages and then those bacteriophages infect another host. Transformation occurs 
when naked AMR DNA is absorbed from the environment. 
Current Applications in Agriculture Industry 
Antimicrobial drugs can be used for many purposes in the agriculture industry. 
According to Viola and DeVincent (2006), antimicrobials can be used to treat illnesses 
ranging from skin to respiratory infections. Secondly, they can be used as a measure to 
prevent specific diseases during certain stages of animal production (also known as 
prophylactic treatment). Third, they can be used to treat large numbers of animals when there 
is a risk of disease spreading in the herd (also known as metaphylactic treatment). Lastly, 
they can be used to improve feed conversion efficiency or rate of gain for production 
purposes. When antimicrobials are used for production purposes, they are often administered 
at subtherapeutic levels (McEwen and Fedorka-Cray, 2002). According to Allen et al. (2013) 
subtherapeutic is defined as using a dosage that is lower than the dosage needed to actually 
treat a disease. The United States Food and Drug Administration recently published 
documents that outlined changes which essentially removed the option for utilizing 
antimicrobials as growth promoters (FDA, 2012). Given the many uses of antimicrobials, 
each time the antimicrobial is used it increases the selective pressure for bacteria to become 
resistant. To address concerns with antimicrobial resistance, several studies were conducted 
to evaluate how the administration of antimicrobials would affect antimicrobial resistance. 
8 
 
Two studies indicated that cattle, which have been administered antimicrobial drugs, have a 
higher likelihood of shedding antimicrobial resistant bacteria in the feces (Alexander et al., 
2008; Sharma et al., 2008). Alexander et al. (2008) evaluated fecal samples from feedlot 
steers. Results indicated that the increase in prevalence of Tetracycline- and Ampicillin-
resistant E. coli was largely due to the administration of Tetracycline with Sulfamethazine. A 
similar study conducted by Sharma et al. (2008) collected fecal samples from beef cattle that 
had been given either Chlortetracycline or Chlortetracycline with Sulfamethazine. Results 
demonstrated that fecal shedding of Tetracycline-resistant commensal E. coli was higher in 
cattle that received the combination of antimicrobials. Although the two previously 
mentioned studies saw increases in antimicrobial resistant bacteria due to the usage of certain 
antimicrobials, there are other studies that have results which conflict with their findings. For 
instance, in a study conducted by Kalmokoff et al. (2011), results indicated that antimicrobial 
resistant genes were present even in the absence of administered antimicrobials. This was 
especially evident in macrolide resistant genes being found in pigs that were not directly 
exposed to antimicrobials. Agga et al. (2015) also found tetracycline resistant genes in pigs 
that had not been directly exposed to antimicrobials. Antimicrobial resistance is a dynamic 
issue in that resistance genes can be found even if an antimicrobial hadn’t been administered. 
Regardless, it is prudent for producers to utilize antimicrobials in a judicious manner (FDA, 
2012). 
Prevention of Antimicrobial Resistance 
For several decades, many countries across the world have recognized that 
antimicrobial resistance is a growing problem that must be addressed accordingly. Food 
animal producers and major industry organizations alike are working towards being better 
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stewards of antibiotic use to prevent antimicrobial resistance. For instance, in the United 
States the Beef Checkoff Program has funded the Beef Quality Assurance (BQA) Program. 
This funding allows the BQA Program to provide materials and manuals for both producers 
and consumers on topics such as “A Beef Producers Guide for Judicious Use of 
Antimicrobials in Cattle” (Beef Quality Assurance, 2015). Also, the U.S. Centers for Disease 
Control and Prevention established the National Antimicrobial Resistance Monitoring 
System for Enteric Bacteria (NARMS) in 1996. This organization was specifically created to 
help monitor and investigate incidences reported by the CDC, Food and Drug Administration 
and United States Department of Agriculture (CDC, 2015b). Likewise, the Food and Drug 
Administration actively monitors the efficacy and safety of medically important 
antimicrobials that are used for both human and animal health. In 2003 the FDA published 
Guidance for Industry #152. This document largely focuses on maintaining the efficacy of 
medically important drugs, protecting the health of both humans and animals, and how to 
mitigate potential risk associated with antimicrobials (FDA, 2003). As a follow up, the FDA 
published Guidance for Industry #209 in April 2012. Guidance for Industry #209 brings forth 
the topic of judiciously using medically important antimicrobials. The FDA considers 
judicious use of antimicrobials beneficial in situations such as prevention, controlling, or 
treating certain diseases. The FDA thinks that the judicious use of medically important 
antimicrobials would motivate people to not use antibiotics for unnecessary or inappropriate 
situations and ultimately reduce the development of antimicrobial resistant bacteria (FDA, 
2012). Also, in 2013 the FDA published Guidance for Industry #213. This guidance called 
for the voluntary elimination of using medically important antimicrobials as growth 
promoters in feed or water (FDA, 2013). This document also focuses on promoting increased 
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veterinary oversight in the initial decision making process on whether to use antimicrobials 
in feed or water. Drug sponsors would be able to voluntarily change product labels to remove 
terms such as “growth promotion” or “increase rate of gain” and add “include veterinary 
oversight” (FDA, 2013). As of January 1, 2017, antimicrobials may not be used in food or 
water for production purposes and a Veterinary Feed Directive must be obtained from a 
veterinarian in order to purchase them (FDA, 2013). 
In 2010, World Organisation for Animal Health (OIE) formed a Tripartite Alliance 
with Food and Agriculture Organization of the United Nations (FAO), OIE, and World 
Health Organization (WHO). They firmly believe that tackling the antimicrobial resistance 
issue needs to be a joint effort between human health and animal health professionals. The 
goals of their alliance consist of: “1) ensure that antimicrobial agents maintain their efficacy, 
2) promote the responsible and prudent use of these agents, and 3) enable access to high-
quality medicines for all” (OIE, 2010). More recently, in May 2015, World Health 
Organization (2015a) proposed a Global Action Plan that would also aid in taking on the 
fight against antimicrobial resistance. Their plan includes five key goals such as: “1) improve 
awareness and understanding of antimicrobial resistance, 2) strengthen knowledge through 
surveillance and research, 3) reduce the incidence of infection, 4) optimize the use of 
antimicrobial agents, and 5) develop the economic case for sustainable investment that takes 
account of the needs of all countries, and increase investment in new medicines, diagnostic 
tools, vaccines and other interventions”. 
Organizations in both the United States and Europe recognize that antimicrobial 
resistance is an ever growing problem that needs to be addressed accordingly. Efforts to 
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reduce or slow antimicrobial resistance should be met with a willingness to cooperate so that 












MATERIALS AND METHODS 
Sample Collection 
 Sample collection procedures used in this study were approved by the Angelo State 
University Institutional Animal Care and Use Committee (Appendix A, Form 16-01). Fecal 
samples were collected from eighty-four market steers (n=84) and market hogs (n=84) of 
varying breed types at a statewide livestock show in Texas. The fecal grab method, collecting 
off of fresh fecal pats, was used on both species. Portions of feces were collected from the 
top most area of fresh fecal pats to preserve the integrity of the sample. A fecal pat was 
deemed ‘fresh’ if it showed signs of moisture and no surface contamination. Only one sample 
was collected per stall to ensure no duplicate animals were tested. Approximately 50g of 
feces was collected using fresh sterile gloves and placed in a sterile collection cup, labeled 
with a unique identification number, and maintained in a cooler with ice packs until 
completion of sample collection. All samples were stored at 4°C in Angelo State University’s 
Food Microbiology Laboratory and processed within 36 hours of collection. 
Escherichia coli Enumeration and Isolation 
 Serial dilutions using Buffered Peptone Water were prepared and plated onto 3M   
E. coli/ Coliform Count Plate® (3M™ Petrifilm™, 2011) and incubated at 37±2°C for 24 
hrs. E. coli populations were enumerated by counting colonies that were blue in color with 
associated gas bubbles as per manufacturer’s guidelines. Four generic E. coli colonies were 
obtained using sterile disposable loops and isolated on MacConkey agar and incubated at 
37±2°C for 24 hrs. Next, four isolated colonies were transferred to a 9 ml tube of Tryptic Soy 
Broth (TSB) and incubated at 37±2°C for 24 hrs. Isolate culture was combined with a sterile 
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1:1 glycerol solution (glycerine:deionized water) and stored in a -81°C freezer until 
antimicrobial susceptibility testing. 
Salmonella Detection and Isolation 
 Salmonella spp. isolation was accomplished by selectively enriching one gram of 
feces in both 9ml of Tetrathionate (TT) broth and 9ml of Rappaport-Vassiliadis (RV) broth 
and incubated at 37±2°C for 24 hrs and 42±2°C for 24 hrs, respectively. Culture obtained 
from both broths was streaked onto Xylose Lysine Tergitol 4 (XLT4) plates and incubated at 
37±2°C for 48 hrs. Samples were presumed positive if they exhibited colonies yellow to red 
in coloring with black centers (Difco-BD, Sparks, MD). Two presumptive positive isolates 
were utilized to inoculate test tubes of TSB and incubated at 37±2°C for 24 hrs. Isolate 
culture was combined with a sterile 1:1 glycerol solution (glycerine:deionized water) and 
stored in a -81°C freezer until further use. Final confirmation of presumptive positive isolates 
was conducted via latex agglutination. Upon thawing for resistance testing, the 
manufacturer’s instructions of the Remel Colex Latex Agglutination Kit were followed and 
isolates were classified into a serogroup (Remel, Lenexa, KS). In brief, previously frozen 
Salmonella culture was streaked onto XLT4 and incubated at 37±2°C for 48 hrs. One well 
isolated colony was streaked onto Tryptic Soy Agar (TSA) and incubated for 37±2°C for 24 
hrs. Next, two colonies were transferred from the TSA plate to a tube of sterile saline 
solution using a sterile disposable loop. The saline solution was then dispensed onto a 
manufacturer provided agglutination card and rotated for two minutes to allow for 




Antimicrobial Susceptibility Testing 
 Escherichia coli isolate culture was streaked onto MacConkey agar plates and 
incubated for 37±2°C for 24 hrs. One well isolated colony was then re-isolated on a TSA 
plate and incubated at 37±2°C for 18-24 hours. One colony was suspended in 4 ml of sterile, 
deionized water and vortexed. The homogenized solution was then adjusted to a 0.5 
McFarland Polymer Turbidity Standard using a Thermo Scientific™ Sensititre™ 
Nephelometer (Thermo Scientific, Lenexa, KS). Ten µl of the suspended solution was 
transferred to 10 ml of Mueller-Hinton (MH) broth. The MH solution was vortexed and 
poured into a sterile seed trough. A multi-chamber pipette was used to transfer 50 µl of MH 
solution from the sterile seed trough to inoculate each of the 96 wells on the Sensititre® 
(CMV3AGNF) plate. Special care was taken to cover the Sensititre® plate with an adhesive 
seal while avoiding creases that would prevent proper sealing. The Sensititre® plates were 
incubated at 34-36°C for 18-24 hours. After incubation, the results were manually read using 
the Sensititre® Manual Viewer (Thermo Scientific). Wells that had a deposit of bacterial cells 
at the bottom of the plate, or cloudy growth throughout, were considered to be resistant to the 
amount of antimicrobial present in that well. Subsequently, the Minimum Inhibitory 
Concentration (MIC) of each antimicrobial was recorded as the lowest concentration of 
antimicrobial that inhibited visible growth. For this study, the Sensititre® plates included 14 
antimicrobials of importance to humans and animals. Names and tested concentration levels 
of these antimicrobials are found in Table 1. 
Antimicrobial susceptibility testing for Salmonella isolate culture was similar to that 
of E. coli except isolate culture was streaked onto XLT4 plates, incubated for 37±2°C for 48 
hrs, and then transferred to TSA plates. 
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Table 1. Antimicrobial agent concentration and breakpoints 
Antimicrobial Agent Concentration, µg/ml MIC Breakpoint, µg/ml* 
Amoxicillin-clavulanic acid 1-32 >32/16 
Ampicillin 1-32 ≥32 
Azithromycin 0.12-16 ≥32 
Cefoxitin 0.5-32 ≥32 
Ceftiofur 0.12-8 ≥8 
Ceftriaxone 0.25-64 ≥4 
Chloramphenicol 2-32 ≥32 
Ciprofloxacin 
    Escherichia coli 







Gentamicin 0.25-16 ≥16 
Nalidixic Acid 0.5-32 ≥32 
Streptomycin 2-64 ≥32 
Sulfisoxazole 16-256 ≥512 
Tetracycline 4-32 ≥16 
Trimethoprim/Sulfamethoxazole 0.12/2.38-4/76 ≥4/76 
*MIC Breakpoint = Minimum Inhibitory Concentration Breakpoint; obtained from the 


















 Various procedures of SAS (Cary, NC; Version 9.1.3) were used to compile 
descriptive statistics. Escherichia coli populations were transformed to a log base 10. 
Significant differences between E. coli populations from market show hogs and steers were 
evaluated using mixed procedures (PROC MIXED) of SAS. Chi square analysis was used to 
determine differences in prevalence of Salmonella between animal species. Isolates were 
classified as resistant or susceptible to each antimicrobial using established breakpoints 
provided by the National Antimicrobial Resistance Monitoring Service (Table 1; NARMS, 
2014). Minimum Inhibitory Concentrations (MIC) were transformed to a log base 2.  
Differences in MIC of each antimicrobial drug between animal species were also analyzed 
using the mixed procedures of SAS. Chi Square Analysis was utilized to evaluate differences 
in frequency of resistant versus susceptible isolates. All significant differences were 














RESULTS & DISCUSSION 
Escherichia coli 
 Fecal samples were analyzed for presence and population level of generic 
Escherichia coli. Out of 168 total fecal samples collected, 97.60% of hogs (82 of 84) were 
positive for generic E. coli, whereas 100% of steers (n=84) were positive.  Escherichia coli 
populations were higher in hogs with an Least Squares Means (LSMeans) of 6.12 log10 
CFU/g of feces compared to steer samples at 5.57 log10 CFU/g (P<0.05). 
 Fourteen antimicrobials were evaluated for antimicrobial susceptibility testing of 
generic E. coli isolates obtained from market show hogs and steers. Of the 662 total generic 
E. coli isolates utilized for antimicrobial susceptibility testing, 98.18% (324 of 330 tested) of 
hog isolates and 63.25% (210 of 332 tested) of steer isolates exhibited resistance to at least 
one of the 14 antimicrobials tested. Additionally, it is important to consider what percentage 
of isolates that exhibited resistance to more than one antimicrobial drug. Of the 14 
antimicrobials that were tested in the panel, 85.16% (281 of 330 tested) market hog isolates 
exhibited resistance to two antimicrobials or more (Figure 1). When evaluating market steer 
isolates, only 36.73% (122 of 332 tested) of isolates were resistant to two antimicrobials or 
more. When evaluating the different resistance patterns shown by the isolates, there were 87 
unique resistance patterns which were exhibited by the E. coli isolates from all livestock 
tested. In market hog isolates, the most common pattern was resistance to Tetracycline alone 





Figure 1. Percentage of generic Escherichia coli isolates obtained from market hogs (n=330) and steers (n=332) based on the 































































Table 2. Most frequent antimicrobial drug resistance patterns of Escherichia coli isolates 
obtained from market show hogs (n=330) and steers (n=332) 












11.82 39 1 Tetracycline 
 
 8.18  27 2 Streptomycin, 
Tetracycline 
 
 7.58  25 2 Sulfisoxazole, 
Tetracycline 
 










36.75  122 0 Pansusceptible* 
 
 21.39  71 1 Tetracycline 
 









 3.31  11 2 Streptomycin, 
Tetracycline 
 *Pansusceptible=susceptible to all antimicrobial drugs tested 
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Streptomycin and Tetracycline in 8.18% of hog isolates. As for market steer isolates, the 
most common pattern of resistance was seen in 36.75% of isolates exhibiting 
pansusceptibilty to all 14 antimicrobial drugs tested. Also, 21.39% of market steer isolates 
had a resistance pattern to Tetracycline alone (Table 2). In a similar study conducted by Roug 
et al. (2013), fecal samples were collected from pigs and dairy cattle at a county fair in 
California and screened for the presence of commensal Escherichia coli. Ten isolates were 
obtained from both species and utilized for antimicrobial resistance testing. Out of the ten pig 
isolates utilized, the most common resistance pattern exhibited was to Tetracycline as it was 
present in all of the patterns. Resistance patterns were also exhibited to Sulfisoxazole, 
Streptomycin, and Chloramphenicol in nine, four, and five of the patterns, respectively. For 
dairy cattle isolates, the most common pattern was to Tetracycline as it was present in three 
patterns (Roug et al., 2013). Similarities were identified in the results from the current study 
and Roug et al. (2013). Notably, the most common resistance pattern exhibited in swine 
isolates from both studies was to Tetracycline. For cattle isolates from both studies, there was 
similar resistance patterns exhibited to Tetracycline as well. Although the current study and 
Roug et al. (2013) were not conducted in the same geographic location, results from both 
studies were based on similar species which provides a common ground for results to be 
compared. For this particular research avenue, it would be beneficial to conduct similar 
studies in other states to see if geographic location plays a role in antimicrobial susceptibility 
of generic Escherichia coli isolates obtained from show animals. 
 During antimicrobial susceptibility testing, minimum inhibitory concentration (MIC) 
breakpoints, provided by the National Antimicrobial Resistance Monitoring System, were 
utilized to determine if bacteria were resistant or susceptible to each of the antimicrobials 
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(NARMS, 2014). When evaluating resistance to the various antimicrobials tested, isolates 
from market hogs exhibited the most common resistance to Tetracycline, Sulfisoxazole, and 
Streptomycin with 96.67%, 69.70%, and 53.64% of isolates exhibiting resistance to the 
respective antimicrobial (Figure 2). Isolates from market steers exhibited the most common 
resistance to Tetracycline, Streptomycin, and Sulfisoxazole with 55.12%, 32.53%, and 
28.61% of isolates exhibiting resistance, respectively (Figure 2). According to the Roug et al. 
(2013) study, out of all commensal E. coli isolates utilized for antimicrobial susceptibility 
testing, isolates from pigs demonstrated resistance to Tetracycline (10 out of 10 isolates), 
Sulfisoxazole (9 out of 10 isolates), and Ampicillin, Chloramphenicol, Kanamycin, and 
Streptomycin (5 out of 10 isolates). Commensal Escherichia coli isolates from cattle in their 
study also demonstrated resistance to Tetracycline (3 out of 10 isolates), Sulfisoxazole (2 out 
of 10 isolates), and Streptomycin, Kanamycin, and Ampicillin (1 out of 10 isolates). Roug et 
al. (2013) also reported that none of the E. coli isolates were resistant to 
Amoxicillin/Clavulanic Acid, Cefoxitin, Ceftiofur, Ciprofloxacin, Gentamicin, and Nalidixic 
Acid. Results from Roug et al. (2013) align with the current study in that more hog isolates, 
when compared to steers/dairy cattle, exhibited resistance to Tetracycline, Sulfisoxazole, 
Ampicillin, Chloramphenicol, and Streptomycin. With livestock designated for show being 
maintained differently than those that are commercially raised, it is important to evaluate 
similarities and differences between market show livestock and commercially raised 











































































188 generic E. coli isolates were obtained from feedlot heifers that were fed a diet of wet 
corn distillers grains with or without the addition of Monensin and Tylosin. Antimicrobial 
susceptibility testing of those isolates revealed that majority were susceptible to 
Aminoglycosides. The current study tested both Gentamicin and Streptomycin which fall 
under the Aminoglycoside antimicrobial class (NARMS, 2014). Notably, results from the 
current study indicated that market show steer isolates exhibited resistance to both 
Streptomycin and Gentamicin with values of 32.53% and 0.6%, respectively. The current 
study did not have access to the diet history of livestock in which fecal samples were 
collected from; it would be beneficial to have that type of information in future research 
evaluating antimicrobial susceptibility of show animals. 
 Table 3 shows the percentage of all market show hog E. coli isolates (n=330) tested 
based on the percent that fell within the various minimum inhibitory concentrations (MIC) 
for each antimicrobial drug on the panel. The largest percentage of isolates exhibited MICs at 
the highest concentration tested for Tetracycline, Ampicillin, Streptomycin, and 
Chloramphenicol with values of 92.73%, 45.45%, 28.18%, and 21.21%, respectively.  
Results from the Jacob et al. (2008) study indicate that none of the generic E. coli isolates 
obtained from feedlot heifers were resistant to Danofloxacin or Enrofloxacin (which are 
classified as Quinolones). In the current study, of the 330 hog isolates tested, 96% exhibited 
MICs of 0.25 µg/ml or less in Ciprofloxacin; which falls into the Quinolone class of drugs. 
This is notably less than the resistant breakpoint of 4 µg/ml. This result is encouraging as 
Ciprofloxacin is important in treating various infections and has been identified by World 




Table 3. Percentage of generic Escherichia coli isolates obtained from market show hogs (n= 330) on the basis of Minimum Inhibitory 
Concentration (MIC) ratio 
MIC Ratio1 
Antimicrobial 0 1 2 3 4 5 6 7 8 9 Lowest 
Concentration 
Tested, µg/ml 
Cefoxitin 0.00 0.00 5.45 49.09 35.76 5.15 0.91 3.64 - - 0.5 
Azithromycin2 0.00 0.00 0.00 1.21 5.76 49.70 36.06 5.45 1.82 - 0.12 
Chloramphenicol 2.42 10.30 42.12 6.36 17.58 21.21 - - - - 2.0 
Tetracycline 2.42 0.91 0.00 3.94 92.73 - - - - - 4.0 
Ceftriaxone 81.21 5.76 4.24 0.91 0.30 0.00 1.21 1.21 1.21 3.94 0.25 
Amoxicillin/Clavulanic Acid 2.12 24.24 41.82 21.52 2.73 6.67 0.91 - - - 1.0/0.5 
Ciprofloxacin 60.00 9.09 2.42 0.61 4.55 19.39 0.91 1.21 0.30 1.52 0.015 
Gentamicin 22.73 53.64 11.82 5.15 3.03 0.91 0.61 2.12 - - 0.25 
Nalidixic Acid 0.00 0.91 42.12 23.03 6.06 19.70 6.36 1.82 - - 0.5 
Ceftiofur 0.30 29.09 55.15 5.76 1.21 0.91 0.91 6.67 - - 0.12 
Sulfisoxazole2 18.79 9.39 1.82 0.00 0.30 69.70 - - - - 16.0 
Trimethoprim/Sulfamethoxazole 63.33 16.67 4.85 1.21 0.30 0.00 13.64 - - - 0.12 
Ampicillin 5.45 32.12 10.61 4.85 0.30 1.21 45.45 - - - 1.0 
Streptomycin 0.61 16.36 18.18 11.21 14.85 10.61 28.18 - - - 2.0 
1 Ratios were obtained by dividing each MIC by the lowest concentration on the specific antimicrobial tested. The ratio was then turned into 
a log base 2 for comparison. 
2 Highlighted dash marks indicate breakpoint not on Sensititre® panel 
- = Value greater than the highest number tested on the panel 
*Shaded values represent isolates considered resistant for individual drugs based on breakpoints established by the National Antimicrobial 





Sulfamethoxazole, Ciprofloxacin, and Sulfisoxazole had the largest percentage of isolates 
exhibiting MICs at the lowest concentration tested with values of 81.21%, 63.33%, 60.00%, 
and 18.79%, respectively. Table 4 displays the percentage of all market show steer E. coli 
isolates (n=332) tested based on the percent that fall within the various MICs for each 
antimicrobial. Tetracycline was the only antimicrobial that displayed the largest percentage 
of isolates exhibiting MICs at the highest concentration tested with a value of 44.28%. 
Additionally, Tetracycline exhibited 37.65% of isolates that had MICs at the lowest 
concentration tested; which leaves the remaining 50% of isolates resistant. Ceftriaxone, 
Trimethoprim/Sulfamethoxazole, Ciprofloxacin, and Sulfisoxazole had the largest percentage 
of isolates exhibiting MICs at the lowest concentration tested with values of 91.87%, 
88.55%, 73.49%, and 54.52%, respectively. It is important to note that Ciprofloxacin did not 
have any isolates with MICs in the four highest concentration levels tested and 97.6% of 
isolates had MICs at or below 0.06 µg/ml. Medically, bacteria with MICs that fall well below 
the breakpoint are more likely to be controlled by the prescribed drug. 
 Lastly, the differences between LSMeans of generic E. coli from market show hogs 
and steers were evaluated on the basis of MICs for antimicrobial agents tested (Table 5). 
Market hog isolates displayed higher MICs in 13 out of 14 tested antimicrobials when 
compared to steer isolates. The most notable differences in LSMeans were observed in 
Sulfisoxazole, Ampicillin, Tetracycline, and Ciprofloxacin. Market hog isolates had an 
LSMean of 7.62 log2 µg/ml for Sulfisoxazole and steers had 5.62 log2 µg/ml (P<0.0001). 
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Table 4. Percentage of generic Escherichia coli isolates obtained from market show steers (n=332) on the basis of Minimum 
Inhibitory Concentration (MIC) ratio 
MIC Ratio1 
Antimicrobial 0 1 2 3 4 5 6 7 8 9 Lowest 
Concentration 
Tested, µg/ml 
Cefoxitin 0.00 0.60 9.34 50.90 32.23 4.82 0.30 1.81 - - 0.5 
Azithromycin2 0.00 0.00 0.00 0.60 10.24 57.23 27.11 3.01 1.81 - 0.12 
Chloramphenicol 1.51 16.87 65.96 5.72 1.81 8.13 - - - - 2.0 
Tetracycline 37.65 7.23 5.12 5.72 44.28 - - - - - 4.0 
Ceftriaxone 91.87 4.22 1.51 0.00 0.30 0.60 0.00 1.20 0.00 0.30 0.25 
Amoxicillin/Clavulanic Acid 8.43 31.93 50.30 6.02 1.20 1.20 0.90 - - - 1.0/0.5 
Ciprofloxacin 73.49 18.98 2.71 1.81 2.41 0.60 0.00 0.00 0.00 0.00 0.015 
Gentamicin 13.25 65.96 15.96 3.31 0.90 0.00 0.30 0.30 - - 0.25 
Naladixic Acid 0.00 1.81 55.72 34.34 4.22 1.81 0.00 2.11 - - 0.5 
Ceftiofur 4.52 30.12 54.22 2.71 5.72 0.60 0.90 1.20 - - 0.12 
Sulfisoxazole2 54.52 14.46 2.11 0.30 0.00 28.61 - - - - 16.0 
Trimethoprim/Sulfamethoxazole 88.55 6.93 1.20 0.60 0.00 0.30 2.41 - - - 0.12 
Ampicillin 12.35 57.53 18.37 2.41 1.51 1.20 6.63 - - - 1.0 
Streptomycin 2.71 21.69 36.45 6.63 7.83 8.43 16.27 - - - 2.0 
1 Ratios were obtained by dividing each MIC by the lowest concentration on the specific antimicrobial tested. The ratio was then 
turned into a log base 2 for comparison. 
2 Highlighted dash marks indicate breakpoint not on Sensititre® panel 
- = Value greater than the highest number tested on the panel 
*Shaded values represent isolates considered resistant for individual drugs based on breakpoints established by the National 





Table 5. Least Squares Means of generic Escherichia coli of Minimum Inhibitory 
Concentrations (MIC) (Log2 µg/ml) for antimicrobial agents tested 





Antimicrobial Drug MIC, µg/ml SE* MIC, µg/ml SE P-valuea 
Cefoxitin 2.57 0.05 2.39 0.05 0.01 
Azithromycin 2.44 0.04 2.27 0.04 0.00 
Chloramphenicol 3.90 0.06 3.13 0.06 <0.0001 
Tetracycline 5.83 0.07 4.11 0.07 <0.0001 
Ceftriaxone -1.20 0.09 -1.77 0.09 <0.0001 
Amoxicillin/clavulanic acid 2.22 0.05 1.66 0.05 <0.0001 
Ciprofloxacin -4.43 0.09 -5.63 0.09 <0.0001 
Gentamicin -0.72 0.06 -0.84 0.06 0.14 
Nalidixic Acid 2.27 0.06 1.56 0.06 <0.0001 
Ceftiofur -0.81 0.07 -1.13 0.07 <0.05 
Sulfisoxazole 7.62 0.11 5.62 0.11 <0.0001 
Trimethoprim/sulfamethoxazole -1.90 0.08 -2.78 0.08 <0.0001 
Ampicillin 3.47 0.10 1.53 0.10 <0.0001 
Streptomycin 4.67 0.10 3.85 0.10 <0.0001 
a MIC values within an antimicrobial that have P<0.05 differ 




Additionally, market hog isolates had an LSMean of 3.47 log2 µg/ml for Ampicillin whereas 
steer isolates had 1.53 log2 µg/ml (P<0.0001). Market hog isolates had an LSMean of 5.83 
log2 µg/ml for Tetracycline and steer isolates had 4.11 log2 µg/ml (P<0.0001). When 
evaluating Ciprofloxacin, hog isolates had an LSMean of -4.43 log2 µg/ml and steers had       
-5.63 log2 µg/ml (P<0.0001).  
The current study did not obtain health or diet records prior to fecal sample 
collection; therefore, a definitive statement identifying the factors that contributed to the 
antimicrobial resistance of generic E. coli isolates obtained cannot be made. Although 
generic E. coli is considered to be non-pathogenic, it still has the potential to gain and 
transfer antimicrobial resistant genes to other bacteria; therefore, it is equally important to 
monitor antimicrobial susceptibility within this group of bacteria (Wells et al., 2014).  
Salmonella spp. 
Fecal samples obtained from market show hogs and steers were analyzed to 
determine the prevalence of Salmonella. Salmonella was more prevalent in hog samples than 
steer samples (P<0.05) with 19.05% of hogs (16 of 84) and 3.61% steers (3 of 83) testing 
positive. Upon completion of agglutination testing, Salmonella isolates confirmed positive 
were placed into one of three serogroups. Of the market show hog isolates obtained, 88.88% 
(16 out of 18) were classified into serogroup B whereas 11.11% (2 out of 18) were classified 
into serogroup E or G. Out of the market steer isolates obtained, 40% (2 out of 5) were 
classified in serogroup B, 40% in serogroup E or G, and 20% (1 out of 5) were classified in 
serogroup C. Since Salmonella spp. isolates were not serotyped in this study, examples of 
potential serotypes and their respective serogroup will be discussed. According to CDC 
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compiled statistics from 1968-2011, S.Typhimurium, S. Heidelberg, and S. Derby fall under 
serogroup B. Out of 52,889 non-human S. Heidelberg isolates collected between 1968-2011, 
2.11% of those were from bovine and 1.55% from porcine (CDC, 2013). Of the 13,958 non-
human S. Derby isolates, 3.29% were from bovine and 66.89% were from porcine. Serotype 
S. Anatum falls under serogroup E . Out of the 16,227 S. Anatum isolates, 19.50% were from 
bovine and 13.83% from porcine. S. Montevideo and S. Newport fall under serogroup C. Of 
the 18,245 S. Montevideo isolates collected, 25.60% were from bovine and 1.10% from 
porcine. Lastly, of the 14,811 S. Newport isolates collected, 49.27% were from bovine and 
2.58% from hogs. Roug et al. (2013) conducted a study in California in which fecal samples 
were collected from dairy cattle and pigs at a county fair. None of the fecal samples collected 
from dairy cattle (16 tested), sheep (35 tested), or goats (11 tested) tested positive for 
Salmonella. However, positive fecal samples were obtained from pigs (7 of 31 tested). Two 
Salmonella Derby isolates were obtained from pigs. In a study conducted by Pabilonia et al. 
(2014), Salmonella was detected on various environmental surfaces (feed, cages, tables, and 
floors) at poultry exhibits within county fairs in Colorado. Of those samples collected, they 
found that at least one sample was positive from 10 out of 11 fairs. Out of all samples 
collected (n=55), Salmonella spp. isolates were obtained from 28 samples (50.9%). 
According to CDC (2017) surveillance data, all aforementioned serotypes, with the exception 
of S. Anatum, have been linked with foodborne illnesses in humans since 2014. 
 Salmonella isolates obtained from fecal samples of market show hogs and steers were 
utilized for antimicrobial susceptibility testing. Of the 18 Salmonella isolates obtained from 
market hogs, 83.33% exhibited resistance to at least one antimicrobial. It is also important to 
consider the percentage of isolates that exhibited resistance based on the number of 
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antimicrobial drugs tested. Of the 14 antimicrobials that were tested in the panel, 55.56% (10 
out of 18 tested) market hog isolates exhibited resistance to two or more antimicrobial agents 
(Table 6). However, market steer isolates exhibited pansusceptibility to all tested 
antimicrobials. Along with analysis of the percent to which resistance was exhibited for a 
number of antimicrobials, there were 10 unique resistance patterns which were exhibited by 
the 23 isolates collected from all livestock. In market hog isolates, a resistance pattern was 
observed with 22.22% isolates resistant to Tetracycline alone and 22.22% resistant to 
Ampicillin, Sulfisoxazole, Streptomycin, and Tetracycline (Table 7). The remainder 
(16.67%) were pansusceptible. Market steers exhibited 100% (5 isolates) pansusceptibilty. 
 When evaluating resistance to the various antimicrobials, isolates from market hogs 
(n=18) exhibited the most common resistance to Tetracycline, Streptomycin, and 
Sulfisoxazole with 77.78%, 44.44% and 44.44% of isolates resistant to the respective 
antimicrobial (Figure 3).  None of the five Salmonella isolates from market steers exhibited 
clinical resistance to any of the tested antimicrobials. In the study conducted by Roug et al. 
(2013), two Salmonella Derby isolates were obtained from pigs. Those isolates were utilized 
for antimicrobial susceptibility testing and were resistant to Florfenicol, Spectinomycin, 
Sulphachloropyridazine, Sulphadimethoxime, Sulphathizole, Chlortetracycline, and 
Oxytetracycline. According to Roug et al. (2013) none of the strains were resistant to 
Ampicillin, Ceftiofur, Gentamicin, or Trimethoprim/Sulphamethoxazole. The results from 
Roug et al. (2013) are similar to results from the current study in which Tetracycline was the 




Table 6. Percentage of Salmonella spp. isolates based on the number of antimicrobial drugs 
to which resistance was exhibited 
# Antimicrobial Agents  % Market Hogs (n=18) % Market Steers (n=5) 
0 16.7 100.00 
1 27.78 0.00 
2 11.11 0.00 
3 0.00 0.00 
4 27.78 0.00 
5 11.11 0.00 
6 0.00 0.00 
7 0.00 0.00 
8 0.00 0.00 
9 5.56 0.00 
10 0.00 0.00 
11 0.00 0.00 
12 0.00 0.00 
13 0.00 0.00 















Table 7. Most frequent antimicrobial drug resistance patterns of Salmonella spp. isolates 
obtained from market show hogs (n=18) and steers (n=5) 
Species Percent Isolates 
Resistant 
(Frequency) 
Number of Drugs 
Resistant 
Antimicrobials to 
Which Isolates were 
Resistant 
Market Hogs 22.22 (4) 1 Tetracycline 
 





16.67 (3) 0 Pansusceptible* 
 
Market Steers 100.00 (5) 0 Pansusceptible* 
 










































































 Table 8 shows the percentage of all market show hog Salmonella spp. isolates (n=23) 
tested based on the minimum inhibitory concentration (MIC) for each antimicrobial drug on 
the panel. The largest percentage of isolates exhibited MICs at the highest concentration 
tested for Tetracycline and Streptomycin with 72.22% and 44.44%, respectively. However, 
Ceftriaxone, Ciprofloxacin, Gentamicin, Nalidixic Acid, and Trimethoprim/ 
Sulfamethoxazole did not have any isolates exhibit MICs at the highest tested concentration. 
Instead, Ceftriaxone, Trimethoprim/Sulfamethoxazole, Amoxicillin/Clavulanic Acid, 
Ampicillin, Gentamicin, and Ciprofloxacin had the largest percentage of isolates exhibiting 
MICs at the lowest level tested with values of 88.89%, 88.89%, 61.11%, 61.11%, 55.56%, 
and 44.44%, respectively. Ciprofloxacin had results similar to those seen in E. coli. Table 9 
displays the percentage of all market show steer E. coli isolates (n=5) tested based on the 
MIC for each antimicrobial. No antimicrobials tested had any isolates that exhibited MICs in 
the highest concentration tested. Given the small and unequal sample size, basic mean 
minimum inhibitory concentrations (MIC) for the antimicrobial agents tested are presented in 
Table 10. When compared to market steer isolates, market hogs had consistently higher 
numerical means MICs. However, true statistical differences were not assessed. Market hogs 
had a mean MIC of 5.05 log2 CFU/g for Tetracycline and steer isolates had 2.00 log2 µg/ml. 
Also, market hog isolates exhibited mean MIC of 2.33 log2 µg/ml for Ampicillin, while steer 
isolates had a mean MIC of 0.00 log2 µg/ml. Next, market hogs exhibited a mean MIC of 
4.88 log2 µg/ml for Streptomycin, whereas steers had a mean MIC of 3.40 log2 µg/ml. 





Table 8. Percentage of Salmonella spp. isolates collected from market show hogs (n=18) on the basis of Minimum Inhibitory Concentration 
(MIC) ratio 
MIC Ratio1 
Antimicrobial 0 1 2 3 4 5 6 7 8 9 Lowest 
Concentration 
Tested, µg/ml 
Cefoxitin 0.00 0.00 38.89 38.89 16.67 0.00 0.00 5.56 - - 0.5 
Azithromycin2 0.00 0.00 0.00 0.00 0.00 72.22 27.78 0.00 0.00 - 0.12 
Chloramphenicol 0.00 22.22 61.11 0.00 5.56 11.11 - - - - 2.0 
Tetracycline 22.22 0.00 0.00 5.56 72.22 - - - - - 4.0 
Ceftriaxone 88.89 0.00 5.56 0.00 0.00 0.00 0.00 5.56 0.00 0.00 0.25 
Amoxicillin/Clavulanic Acid 61.11 0.00 22.22 5.56 0.00 0.00 11.11 - - - 1.0/0.5 
Ciprofloxacin 44.44 44.44 5.56 0.00 0.00 5.56 0.00 0.00 0.00 0.00 0.015 
Gentamicin 55.56 21.78 11.11 0.00 0.00 0.00 5.56 0.00 - - 0.25 
Nalidixic Acid 0.00 0.00 33.33 55.56 0.00 0.00 11.11 0.00 - - 0.5 
Ceftiofur 0.00 0.00 5.56 77.78 5.56 5.56 0.00 5.56 - - 0.12 
Sulfisoxazole2 5.56 27.78 11.11 5.56 5.56 44.44 - - - - 16.0 
Trimethoprim/Sulfamethoxazole 88.89 11.11 0.00 0.00 0.00 0.00 0.00 - - - 0.12 
Ampicillin 61.11 0.00 0.00 0.00 0.00 0.00 38.89 - - - 1.0 
Streptomycin 0.00 11.11 22.22 22.22 0.00 0.00 44.44 - - - 2.0 
1 Ratios were obtained by dividing each MIC by the lowest concentration on the specific antimicrobial tested. The ratio was then turned into 
a log base 2 for comparison. 
2 Highlighted dash marks indicate breakpoint not on Sensititre® panel 
- = Value greater than the highest number tested on the panel 
*Shaded values represent isolates considered resistant for individual drugs based on breakpoints established by the National Antimicrobial 





Table 9. Percentage of Salmonella spp. isolates collected from market show steers (n=5) on the basis of Minimum Inhibitory 
Concentration (MIC) ratio 
MIC Ratio1 
Antimicrobial 0 1 2 3 4 5 6 7 8 9 Lowest 
Concentration 
Tested, µg/ml 
Cefoxitin 0.00 0.00 60.00 40.00 0.00 0.00 0.00 0.00 - - 0.5 
Azithromycin2 0.00 0.00 0.00 0.00 0.00 80.00 20.00 0.00 0.00 - 0.12 
Chloramphenicol 20.00 60.00 20.00 0.00 0.00 0.00 - - - - 2.0 
Tetracycline 100.00 0.00 0.00 0.00 0.00 - - - - - 4.0 
Ceftriaxone 100.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 
Amoxicillin/Clavulanic Acid 100.00 0.00 0.00 0.00 0.00 0.00 0.00 - - - 1.0/0.5 
Ciprofloxacin 80.00 20.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.015 
Gentamicin 100.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - - 0.25 
Nalidixic Acid 0.00 0.00 20.00 80.00 0.00 0.00 0.00 0.00 - - 0.5 
Ceftiofur 0.00 0.00 40.00 40.00 20.00 0.00 0.00 0.00 - - 0.12 
Sulfisoxazole2 0.00 0.00 80.00 0.00 20.00 0.00 - - - - 16.0 
Trimethoprim/Sulfamethoxazole 80.00 0.00 0.00 20.00 0.00 0.00 0.00 - - - 0.12 
Ampicillin 100.00 0.00 0.00 0.00 0.00 0.00 0.00 - - - 1.0 
Streptomycin 0.00 0.00 60.00 40.00 0.00 0.00 0.00 - - - 2.0 
1 Ratios were obtained by dividing each MIC by the lowest concentration on the specific antimicrobial tested. The ratio was then turned 
into a log base 2 for comparison. 
2 Highlighted dash marks indicate breakpoint not on Sensititre® panel. 
- = Value greater than the highest number tested on the panel 
*Shaded values represent isolates considered resistant for individual drugs based on breakpoints established by the National Antimicrobial 




Table 10. Salmonella spp. Mean Minimum Inhibitory Concentrations (MIC) (Log2 µg/ml) 
for antimicrobial agents tested 
 Market Hogs (n=18) Market Steers (n=5) 
Antimicrobial Drug MIC, µg/ml SE* MIC, µg/ml SE 
Cefoxitin 2.00 0.29 1.40 0.24 
Azithromycin 2.27 0.10 2.20 0.20 
Chloramphenicol 3.22 0.28 2.00 0.31 
Tetracycline 5.05 0.39 2.00 0.00 
Ceftriaxone -1.50 0.39 -2.00 0.00 
Amoxicillin/clavulanic acid 1.27 0.47 0.00 0.00 
Ciprofloxacin -5.22 0.28 -5.85 0.20 
Gentamicin -1.16 0.34 -2.00 0.00 
Nalidixic Acid 2.00 0.28 1.80 0.20 
Ceftiofur 0.33 0.25 -0.20 0.37 
Sulfisoxazole 7.11 0.45 6.40 0.40 
Trimethoprim/sulfamethoxazole -2.94 0.08 -2.44 0.61 
Ampicillin 2.33 0.70 0.00 0.00 
Streptomycin 4.88 0.47 3.40 0.24 
*SE= Standard Error 
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isolates and 0.00 log2 µg/ml for steers. Lastly, market hogs had a mean MIC of 3.22 log2 
µg/ml for Chloramphenicol, while steers had 2.00 log2 µg/ml. 
 Overall concern with Salmonella contamination is that it can be spread from the 
environmental surfaces to exhibitors, thereby causing the contamination to spread to other 
surfaces or people at county fairs and even petting zoos; potentially causing Salmonellosis 
(Pabilonia et al., 2014; Roug et al., 2013; Keen et al., 2007). If a human were to consume a 
food product contaminated with antimicrobial resistant bacteria, the outcome could 




 Antibiotic resistance is a dynamic issue for both humans and animals. However, little 
research focuses on where market show animals fit into that dynamic. The aim of this study 
was to evaluate the prevalence and antimicrobial susceptibility of generic Escherichia coli 
and Salmonella spp. in the feces of market show hogs and steers. Results obtained from this 
study indicate that market show hogs had higher levels of bacterial populations and obtained 
isolates were consistently more resistant to the tested antimicrobial agents when compared to 
steers. This study provides additional data to support the need for antimicrobial susceptibility 
surveillance on both commensal and pathogenic bacteria. This area of research would benefit 
from a future study that evaluated prior health and diet records as well as collecting 
additional prevalence and antimicrobial susceptibility data to determine factors that 
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